John is a member of Mintz Levin’s Corporate & Securities practice. Biotechnology, life science, medical device and clean technology companies rely on his 30 years of experience to advise them on a broad range of legal issues, including on the structuring of collaborative research and development efforts, strategic alliances and joint ventures. John’s practice is focused heavily on transactions involving licensing and technology “spin-outs,” sponsored research, and supply and distribution relationships. He has successfully concluded numerous deals, many in an international context, and represents clients worldwide.
John is a frequent panelist at conferences and executive education courses and speaks often on the subject of licensing and collaborative research and development agreements.
Clients in particular appreciate John’s prior experience as general counsel to the Biosciences group of Fisher Scientific International, Inc., where he was responsible for, among other matters, the conduct of acquisitions and subsequent integration efforts, negotiation of licenses, and procurement and supply agreements with life science industry partners.
Professional & Community Involvement
- Member, Licensing Executives Society
- Member, MassINSIGHT Life Science Working Group
- Member, Personalized Medicine Coalition Policy Committee